Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

J. Y. Lee; G. Kim; Y. H. Lee; B. W. Lee; B. S. Cha; C. M. Nam; E. S. Kang

doi:10.1016/j.diabet.2017.06.007

Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

J. Y. Lee, G. Kim, Y. H. Lee, B. W. Lee, B. S. Cha, C. M. Nam, E. S. Kang

Department of Internal Medicine

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	83-85
Number of pages	3
Journal	Diabetes and Metabolism
Volume	45
Issue number	1
DOIs	https://doi.org/10.1016/j.diabet.2017.06.007
Publication status	Published - 2019 Jan

Bibliographical note

Funding Information:
This work was funded by the Bio & Medical Technology Development Program of the NRF, Korea, MSIP (2016R1A2B4013029 to E.S. Kang).

All Science Journal Classification (ASJC) codes

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.diabet.2017.06.007

Cite this

@article{384dc62f73154ae68e6a45854e7f87b7,

title = "Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide",

author = "Lee, {J. Y.} and G. Kim and Lee, {Y. H.} and Lee, {B. W.} and Cha, {B. S.} and Nam, {C. M.} and Kang, {E. S.}",

note = "Funding Information: This work was funded by the Bio & Medical Technology Development Program of the NRF, Korea, MSIP (2016R1A2B4013029 to E.S. Kang). ",

year = "2019",

month = jan,

doi = "10.1016/j.diabet.2017.06.007",

language = "English",

volume = "45",

pages = "83--85",

journal = "Diabetes and Metabolism",

issn = "1262-3636",

publisher = "Elsevier Masson s.r.l.",

number = "1",

}

TY - JOUR

T1 - Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

AU - Lee, J. Y.

AU - Kim, G.

AU - Lee, Y. H.

AU - Lee, B. W.

AU - Cha, B. S.

AU - Nam, C. M.

AU - Kang, E. S.

N1 - Funding Information: This work was funded by the Bio & Medical Technology Development Program of the NRF, Korea, MSIP (2016R1A2B4013029 to E.S. Kang).

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85026539252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026539252&partnerID=8YFLogxK

U2 - 10.1016/j.diabet.2017.06.007

DO - 10.1016/j.diabet.2017.06.007

M3 - Letter

C2 - 28778564

AN - SCOPUS:85026539252

SN - 1262-3636

VL - 45

SP - 83

EP - 85

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

IS - 1

ER -

Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this